ChristopherGTretterMD

Oncology • South Portland, ME

Physician

Join to view full profile

Dr. Tretter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tretter's full profile

Already have an account?

Office
MaineHealth Cancer Care
265 Western Ave Suite 2
South Portland, ME 04106
Phone+1 207-661-0200

Fax+1 781-744-5245

Education & Training

Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1997 - 2000
McGill University Faculty of MedicineClass of 1994

Certifications & Licensure

NH State Medical License 2000 - Present
ME State Medical License 2023 - 2026
MA State Medical License 2007 - 2024
OH State Medical License 2007 - 2009
PA State Medical License 2006 - 2008
VT State Medical License 1998 - 2006

Clinical Trials

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma Start of enrollment: 2004 Feb 01
Completed
Phase 1
Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer Start of enrollment: 2008 Apr 01
Withdrawn
Phase 2
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer Start of enrollment: 2013 Mar 08
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

582 citations
Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma
David F. McDermott, Meredith M. Regan, Joseph I. Clark, Lawrence E. Flaherty, Geoffery R. Weiss
Journal of Clinical Oncology. 2005-01-01
218 citations
Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial
Joseph I. Clark, Michael B. Atkins, Walter J. Urba, Steven Creech, Robert A. Figlin
Journal of Clinical Oncology. 2003-08-15
196 citations
Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, a...
Toni K. Choueiri, Susanna Jacobus, Joaquim Bellmunt, Angela Qu, Leonard Joseph Appleman
Journal of Clinical Oncology. 2014-06-20